Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685750 · ClinicalTrials.gov registry record · NA
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
A NA study, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT00685750 is a NA study that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 88 participants.
The verdict
NCT00685750, a NA study, was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This study intends to analyze the expression of specific sets of markers in tumor samples and in serum from patients with Non-Small Cell lung Cancer (NSCLC) or Stage III or IV melanoma. The data obtained in this study will be used to guide future development of immunotherapies for melanoma or NSCLC patients. Moreover, the analyses will contribute to definition of markers potentially predictive of clinical response to specific anticancer therapies.
Interventions
- PROCEDURE Collection of tumor and blood samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2008-04-28 |
| Est. Completion | 2013-12-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00685750
The ClinicalTrials.gov registry entry for NCT00685750 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collection of tumor and blood samples is the first listed.
NCT00685750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00685750 about?
NCT00685750 is a clinical study titled "Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma". This study intends to analyze the expression of specific sets of markers in tumor samples and in serum from patients with Non-Small Cell lung Cancer (NSCLC) or Stage III or IV melanoma. The data obtained in this study will be used to guide future development of immunotherapies for melanoma or NSCLC ...
What is the current status of trial NCT00685750?
This trial is currently terminated. It is a NA study. The enrollment target is 88 participants. The study started on 2008-04-28. Estimated completion is 2013-12-17.
What interventions are being tested in trial NCT00685750?
The interventions under investigation include: Collection of tumor and blood samples (PROCEDURE).
Who is sponsoring clinical trial NCT00685750?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.